Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structural and molecular basis of PCNA-activated FAN1 nuclease function in DNA repair.

Nature communications·2025
Same author

A Randomized Clinical Trial Evaluating Lactiplantibacillus Plantarum for the Prevention of GI aGvHD: A Report From the Children's Oncology Group (ACCL1633).

Transplantation and cellular therapy·2025
Same author

Structural and molecular basis of FAN1 defects in promoting Huntington's disease.

bioRxiv : the preprint server for biology·2024
Same author

Transanal haemorrhoidal dearterialization(THD) versus open haemorrhoidectomy.

Irish medical journal·2023
Same author

Clinical triad of fat embolism syndrome.

QJM : monthly journal of the Association of Physicians·2021
Same author

Pro-poor policies and improvements in maternal health outcomes in India.

BMC pregnancy and childbirth·2021
Same journal

Lineage-restricted dependency on an oncofetal SNHG29-IGF2BP1 RNA axis in acute megakaryoblastic leukemia.

Leukemia·2026
Same journal

Selective targeting of RSK signaling with PMD-026 suppresses FLT3-activated acute myeloid leukemia while sparing normal hematopoiesis.

Leukemia·2026
Same journal

FATP2-mediated lipid metabolism enhances chimeric antigen receptor T-cell therapy resistance in B-cell acute lymphoblastic leukemia.

Leukemia·2026
Same journal

Spatial remodeling of bone marrow architecture defines tissue-state signatures of disease activity and therapeutic response in myelodysplastic neoplasms.

Leukemia·2026
Same journal

Selective sensitivity of Ph-like B-cell acute lymphoblastic leukemia to BRG1 inhibition identifies a therapeutic vulnerability.

Leukemia·2026
Same journal

Unpacking the epigenetic landscape of acute lymphoblastic leukemia: resolving cellular heterogeneity and nutritional complexities.

Leukemia·2026
See all related articles

Related Experiment Video

Updated: Jun 18, 2026

Profiling Individual Human Embryonic Stem Cells by Quantitative RT-PCR
09:03

Profiling Individual Human Embryonic Stem Cells by Quantitative RT-PCR

Published on: May 29, 2014

AC133 expression in human stem cells.

M Bhatia1

  • 1The John P Robarts Research Institute, Developmental Stem Cell Biology, The University of Western Ontario, Ontario, Canada.

Leukemia
|October 30, 2001
PubMed
Summary
This summary is machine-generated.

AC133 cell surface marker identifies hematopoietic stem cells and progenitor cells. Recent studies reveal AC133 expression in non-hematopoietic tissues, expanding its role beyond blood cell development.

More Related Videos

Differentiation of a Human Neural Stem Cell Line on Three Dimensional Cultures, Analysis of MicroRNA and Putative Target Genes
10:48

Differentiation of a Human Neural Stem Cell Line on Three Dimensional Cultures, Analysis of MicroRNA and Putative Target Genes

Published on: April 12, 2015

Hemogenic Reprogramming of Human Fibroblasts by Enforced Expression of Transcription Factors
11:42

Hemogenic Reprogramming of Human Fibroblasts by Enforced Expression of Transcription Factors

Published on: November 4, 2019

Related Experiment Videos

Last Updated: Jun 18, 2026

Profiling Individual Human Embryonic Stem Cells by Quantitative RT-PCR
09:03

Profiling Individual Human Embryonic Stem Cells by Quantitative RT-PCR

Published on: May 29, 2014

Differentiation of a Human Neural Stem Cell Line on Three Dimensional Cultures, Analysis of MicroRNA and Putative Target Genes
10:48

Differentiation of a Human Neural Stem Cell Line on Three Dimensional Cultures, Analysis of MicroRNA and Putative Target Genes

Published on: April 12, 2015

Hemogenic Reprogramming of Human Fibroblasts by Enforced Expression of Transcription Factors
11:42

Hemogenic Reprogramming of Human Fibroblasts by Enforced Expression of Transcription Factors

Published on: November 4, 2019

Area of Science:

  • Hematology
  • Stem Cell Biology
  • Immunophenotyping

Background:

  • Cell surface markers aid in characterizing human hematopoietic cell subsets.
  • Understanding cell phenotype and function is key to defining hematopoietic hierarchy.
  • AC133 (prominin-1) is a cell surface marker of interest in hematopoiesis.

Purpose of the Study:

  • To review the role of AC133 expression in human hematopoiesis.
  • To discuss novel insights into hematopoietic progenitor and stem cells.
  • To explore AC133 expression in non-hematopoietic tissues.

Main Methods:

  • Isolation and characterization of AC133-expressing human hematopoietic cells.
  • Utilizing in vitro and in vivo assays for functional analysis.
  • Comparative analysis of cell subpopulations based on phenotype.

Main Results:

  • AC133 identifies primitive hematopoietic progenitor and stem cells.
  • AC133 expression is also found in unique cell populations in non-hematopoietic tissues.
  • Phenotype-function relationships define the human hematopoietic system's organization.

Conclusions:

  • AC133 is a significant marker for human hematopoietic stem and progenitor cells.
  • AC133's presence in non-hematopoietic tissues suggests broader biological roles.
  • Further research into AC133 utility in human biology is warranted.